Omeros Corp (OMER) Stock Price, Quote, News & History

OMERNASDAQ
$11.92
0.272.32%
Last update: May 27, 10:10 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-94.76M
Investing Cash Flow (TTM)
154.72M
Financing Cash Flow (TTM)
-62.31M
Free Cash Flow (TTM)
-94.78M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.36M

Analyst Trends and Forecast

2
Dec 25
3
Jan
1
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$856.70M
PE Ratio (TTM)
10.22
PE Ratio (FWD)
61.35
PEG Ratio (TTM)
-
PS Ratio (TTM)
84.23
PB Ratio (TTM)
-
Earnings Yield % (TTM)
9.79%
Earnings Yield % (FWD)
1.63%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.88

Company Debt

Total Debt
$136.84M
LT Debt
$136.84M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$109.19M
Total Cash
$1.91M
Debt to Equity
-
Issuance of Debt (TTM)
-$109.19M
Repayment of Debt (TTM)
-$109.19M

Key Statistics

Open
$11.77
Close
-
Volume / Avg.
117.89K / 1.18M
Day Range
$11.74 - $12.02
52 Wk Range
2.95 - 17.65
Market Cap
$862.71M
P/E Ratio
10.22
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
22.62%
Days to Cover
13.09

About

Sector
Health Care
Industry
Pharmaceuticals
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Omeros (OMER) stock?

A

You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Omeros (OMER) competitors?

A

There are no as such competitors for Omeros.

Q

What is the forecast, or price target, for Omeros (OMER) stock?

A

Omeros has a consensus price target of $27.80.

Q

What is the current price for Omeros (OMER)?

A

The stock price for Omeros (NASDAQ: OMER) is $11.92 last updated May 27, 2026 at 10:10 AM EDT.

Q

Does Omeros (OMER) pay a dividend?

A

There are no upcoming dividends for Omeros.

Q

When is Omeros (NASDAQ:OMER) reporting earnings?

A

Omeros does not have any upcoming earnings scheduled.

Q

Is Omeros (OMER) going to split?

A

There is no upcoming split for Omeros.

Q

What sector and industry does Omeros (OMER) operate in?

A

Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.